Cargando…

Identification of two HLA-A*0201 immunogenic epitopes of lactate dehydrogenase C (LDHC): potential novel targets for cancer immunotherapy

Lactate dehydrogenase C (LDHC) is an archetypical cancer testis antigen with limited expression in adult tissues and re-expression in tumors. This restricted expression pattern together with the important role of LDHC in cancer metabolism renders LDHC a potential target for immunotherapy. This study...

Descripción completa

Detalles Bibliográficos
Autores principales:	Thomas, Remy, Shaath, Hibah, Naik, Adviti, Toor, Salman M., Elkord, Eyad, Decock, Julie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7044258/ https://www.ncbi.nlm.nih.gov/pubmed/31932876 http://dx.doi.org/10.1007/s00262-020-02480-4

Ejemplares similares

Transcriptomic Analyses Revealed Systemic Alterations in Gene Expression in Circulation and Tumor Microenvironment of Colorectal Cancer Patients
por: Shaath, Hibah, et al.
Publicado: (2019)

DNA methylation and repressive histones in the promoters of PD-1, CTLA-4, TIM-3, LAG-3, TIGIT, PD-L1, and galectin-9 genes in human colorectal cancer
por: Sasidharan Nair, Varun, et al.
Publicado: (2018)

Integrated whole transcriptome and small RNA analysis revealed multiple regulatory networks in colorectal cancer
por: Shaath, Hibah, et al.
Publicado: (2021)

Targeting of lactate dehydrogenase C dysregulates the cell cycle and sensitizes breast cancer cells to DNA damage response targeted therapy
por: Naik, Adviti, et al.
Publicado: (2021)

Identification of a HLA-A*0201-restricted immunogenic epitope from the universal tumor antigen DEPDC1
por: Tosi, Anna, et al.
Publicado: (2017)

Lactate Metabolism and Immune Modulation in Breast Cancer: A Focused Review on Triple Negative Breast Tumors
por: Naik, Adviti, et al.
Publicado: (2020)

Long non-coding RNA (lncRNA) transcriptional landscape in breast cancer identifies LINC01614 as non-favorable prognostic biomarker regulated by TGFβ and focal adhesion kinase (FAK) signaling
por: Vishnubalaji, Radhakrishnan, et al.
Publicado: (2019)

Single-Cell Transcriptome Analysis Highlights a Role for Neutrophils and Inflammatory Macrophages in the Pathogenesis of Severe COVID-19
por: Shaath, Hibah, et al.
Publicado: (2020)

HLA-A*0201-restricted CD8(+) T-cell epitopes identified in dengue viruses
por: Duan, Zhi-Liang, et al.
Publicado: (2012)

Identification of Novel HLA-A*0201-Restricted CTL Epitopes in Chinese Vitiligo Patients
por: Cui, Tingting, et al.
Publicado: (2016)

Identification of new HLA-A*0201-restricted cytotoxic T lymphocyte epitopes from neuritin
por: Yang, Zhao, et al.
Publicado: (2013)

HLA-A*0201-specific epitopes of Indian HIV-1C as candidates for vaccine design
por: Sundaramurthi, Jagadish Chandrabose, et al.
Publicado: (2012)

Prediction and identification of novel HLA-A*0201-restricted cytotoxic T lymphocyte epitopes from endocan
por: Shao, Gaohai, et al.
Publicado: (2020)

Comparison of Myeloid Cells in Circulation and in the Tumor Microenvironment of Patients with Colorectal and Breast Cancers
por: Toor, Salman M., et al.
Publicado: (2017)

HLA-A*0201-restricted CTL epitope of a novel osteosarcoma antigen, papillomavirus binding factor
por: Tsukahara, Tomohide, et al.
Publicado: (2009)

Identification of an HLA-A(*)0201-restricted T-cell epitope derived from the prostate cancer-associated protein prostein
por: Kiessling, A, et al.
Publicado: (2004)

Identification of Two Novel HLA-A*0201-Restricted CTL Epitopes Derived from MAGE-A4
por: Jia, Zheng-Cai, et al.
Publicado: (2010)

Complex antigen presentation pathway for an HLA-A*0201-restricted epitope from Chikungunya 6K protein
por: Lorente, Elena, et al.
Publicado: (2017)

Identification of a First Human Norovirus CD8(+) T Cell Epitope Restricted to HLA-A(*)0201 Allele
por: Malm, Maria, et al.
Publicado: (2018)

HLA-A(∗)0201 T-cell epitopes in severe acute respiratory syndrome (SARS) coronavirus nucleocapsid and spike proteins
por: Tsao, Yeou-Ping, et al.
Publicado: (2006)

DNA methylation in the promoters of PD-L1, MMP9, ARG1, galectin-9, TIM-3, VISTA and TGF-β genes in HLA-DR(–) myeloid cells, compared with HLA-DR(+) antigen-presenting cells
por: Saleh, Reem, et al.
Publicado: (2020)

Identification of a novel conserved HLA-A*0201-restricted epitope from the spike protein of SARS-CoV
por: Lv, Yanbo, et al.
Publicado: (2009)

Identification of human LDHC4 as a potential target for anticancer drug discovery
por: Tan, Hong, et al.
Publicado: (2022)

Editorial of Harnessing the Power of T Cells: The Promising Hope for a Universal Influenza Vaccine
por: Toor, Salman M., et al.
Publicado: (2020)

CD8(+) T cell response in HLA-A*0201 transgenic mice is elicited by epitopes from SARS-CoV S protein
por: Zhao, Kai, et al.
Publicado: (2010)

Identification of an HLA-A*0201–restricted CD8(+) T-cell epitope SSp-1 of SARS-CoV spike protein
por: Wang, Baomei, et al.
Publicado: (2004)

The Obesity Paradox in Cancer, Tumor Immunology, and Immunotherapy: Potential Therapeutic Implications in Triple Negative Breast Cancer
por: Naik, Adviti, et al.
Publicado: (2019)

The evolutionary significance of certain amino acid substitutions and their consequences for HIV-1 immunogenicity toward HLA's A*0201 and B*27
por: Hecht, Luke, et al.
Publicado: (2013)

Commentary: Cancer-testis antigen lactate dehydrogenase C4 as a novel biomarker of male infertility and cancer
por: Naik, A., et al.
Publicado: (2023)

Tanshinone IIA inhibits osteoclastogenesis in rheumatoid arthritis via LDHC-regulated ROS generation
por: Peng, Qiuwei, et al.
Publicado: (2023)

Development of a T Cell Receptor Targeting an HLA-A*0201 Restricted Epitope from the Cancer-Testis Antigen SSX2 for Adoptive Immunotherapy of Cancer
por: Abate-Daga, Daniel, et al.
Publicado: (2014)

Breast Cancer Cells and PD-1/PD-L1 Blockade Upregulate the Expression of PD-1, CTLA-4, TIM-3 and LAG-3 Immune Checkpoints in CD4(+) T Cells
por: Saleh, Reem, et al.
Publicado: (2019)

Editorial: Cancer testis antigens in cancer: Recent developments as cancer biomarkers and therapeutic targets
por: Naik, Adviti, et al.
Publicado: (2022)

Immune checkpoint inhibitors: recent progress and potential biomarkers
por: Darvin, Pramod, et al.
Publicado: (2018)

Role of Epigenetic Modifications in Inhibitory Immune Checkpoints in Cancer Development and Progression
por: Saleh, Reem, et al.
Publicado: (2020)

Induction of T-cell response by a DNA vaccine encoding a novel HLA-A*0201 severe acute respiratory syndrome coronavirus epitope
por: Cheung, Ying-Kit, et al.
Publicado: (2007)

Patterns of Immunodominance in HIV-1–specific Cytotoxic T Lymphocyte Responses in Two Human Histocompatibility Leukocyte Antigens (HLA)-identical Siblings with HLA-A*0201 Are Influenced by Epitope Mutation
por: Goulder, P.J.R., et al.
Publicado: (1997)

Immunogenicity Evaluation of a Rationally Designed Polytope Construct Encoding HLA-A*0201 Restricted Epitopes Derived from Leishmania major Related Proteins in HLA-A2/DR1 Transgenic Mice: Steps toward Polytope Vaccine
por: Seyed, Negar, et al.
Publicado: (2014)

EGFR T790M Mutation as a Possible Target for Immunotherapy; Identification of HLA-A*0201-Restricted T Cell Epitopes Derived from the EGFR T790M Mutation
por: Yamada, Teppei, et al.
Publicado: (2013)

Cancer testis antigen PRAME: An anti‐cancer target with immunomodulatory potential
por: Naik, Adviti, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_6fdga4ilrs1sfi7vff8h18s8fo